.avif)
.avif)
Azurity Pharmaceuticals Email Format
Pharmaceutical Manufacturing
・
501-1,000 employees
・
Woburn, MA, USA
Azurity Pharmaceuticals is a privately held global pharmaceutical company that develops and tailors innovative medicines to address unmet needs of overlooked patient populations.
Search our verified sources for decision-makers, emails, and titles.
Start searching
VERIFIED BY CLAY
first.last@azurity.com
Company Overview
Industry
Pharmaceutical Manufacturing
Founded
2012
Headquarters
Woburn, MA, USA
Revenue
$250M-$500M
FUNDING Stage
Private
Website
Key Executives
Ronald L. Scarboro (Chief Executive Officer), Ronald van der Rol (Head of Corporate Marketing & Communications)
Tech Stack
Key Executives
4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified
Frequently Asked Questions
What is the email format of Azurity Pharmaceuticals?
Azurity Pharmaceuticals uses the first.last format on azurity.com, so Jane Smith would be jane.smith@azurity.com.
What therapeutic areas does Azurity Pharmaceuticals focus on?
Azurity Pharmaceuticals markets FDA-approved branded medicines across ten key therapeutic areas, including cardiovascular, central nervous system, oncology, endocrinology, hematology, and gastrointestinal, with a portfolio of 50 or more medicines spanning ten dosage forms.
How can I find and verify a specific contact at Azurity Pharmaceuticals for outreach?
Since Azurity Pharmaceuticals follows the first.last@azurity.com format, you can build addresses directly from a contact's name. A tool like Clay can help you verify those addresses and enrich your prospect list with role and department details before reaching out.
Does Azurity Pharmaceuticals have an oncology product line?
Yes, Azurity Pharmaceuticals markets several oncology products, including GLIADEL Wafer, XATMEP, DANZITEN, and VIVIMUSTA, as part of a broader portfolio that spans ten therapeutic areas and ten dosage forms.
Which countries does Azurity Pharmaceuticals operate in following its acquisition of Covis Pharma?
After completing its acquisition of Covis Pharma in March 2025, Azurity Pharmaceuticals now has a commercial presence in over 50 countries, with employees across North America, Europe, and Asia.
Get access to more people and company data using Clay
Leverage the power of 100+ data providers for industry-leading data coverage & quality.
4.9 rating